AMENDMENT NO. 3 TO THE SEPARATION AND DISTRIBUTION AGREEMENTSeparation and Distribution Agreement • November 6th, 2020 • Mylan N.V. • Pharmaceutical preparations
This Amendment No. 3 (this “Amendment”) to the Separation and Distribution Agreement, dated as of July 29, 2019, as amended (the “Agreement”), is made as of September 18, 2020 by and between Pfizer Inc., a Delaware corporation (“Pluto”) and Upjohn Inc., a Delaware corporation and wholly owned Subsidiary of Pluto (“Spinco”). Each of the foregoing parties is referred to herein as a “Party” and collectively as the “Parties.”
DATED 7 September 2020 ASPEN GLOBAL INCORPORATED and MYLAN IRELAND LIMITED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 6th, 2020 • Mylan N.V. • Pharmaceutical preparations • England and Wales
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • November 6th, 2020 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
This Separation Agreement and Release (“Agreement”) is made by and between Kenneth S. Parks (“Executive”) and Mylan Inc. (together with its affiliates, the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
